Bessemer Group Inc Global Blood Therapeutics, Inc. Transaction History

Bessemer Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$22.3 - $37.39 $3,568 - $5,982	-160 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $13,239 - $17,289	-340 Reduced 68.0%	160 $6,000
Q4 2020 Feb 09, 2021	SELL	$37.65 - $63.77 $5,647 - $9,565	-150 Reduced 23.08%	500 $22,000
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $18,466 - $26,071	-350 Reduced 35.0%	650 $36,000
Q2 2020 Aug 05, 2020	BUY	$48.73 - $81.82 $48,730 - $81,820	1,000 New	1,000 $63,000
Q4 2017 Jan 30, 2018	SELL	$29.7 - $45.7 $1.49 Million - $2.29 Million	-50,009 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$25.1 - $31.05 $1.26 Million - $1.55 Million	50,009	50,009 $1.55 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.